Literature DB >> 8608985

Human papilloma viruses and p53 mutations in normal pre-malignant and malignant oral epithelia.

E J Mao1, S M Schwartz, J R Daling, D Oda, L Tickman, A M Beckmann.   

Abstract

HPV infections have been previously observed in oral cancers, and inactivation of the p53 gene has been shown to be one of the most common genetic alterations in human tumors. We examined 179 oral specimens from 70 individuals with histologic findings of either normal mucosa (n = 6) or oral disease that ranged from mild dysplasia to invasive squamous-cell carcinoma (n = 64) to determine the occurrence of both HPV infection and p53 mutations and their relationship with several clinical factors. HPV infection was detected by PCR amplification of viral DNA, and the presence of p53 mutations was assayed using the single-strand conformation polymorphism (SSCP)-PCR technique. HPV infection was found in 31% of individuals with oral disease and was not seen in healthy individuals. Mutations in exons 5, 6, 7 or 8 of the p53 gene were detected in 37.5% of patients with oral lesions and in a biopsy from 1 healthy individual who was a heavy smoker. Approximately one-third of lesions classified as pre-malignant (dysplasia and carcinoma in situ) and 42% of invasive carcinomas contained p53 mutations. The majority of these mutations were G:T transversions located within exons 7 and 8. Tumor tissues from 6 patients with oral lesions were found both to be HPV-16-positive and to contain p53 mutations; of these, 4 were poorly differentiated carcinomas that were diagnosed as late-stage disease. In this study, p53 mutations were detected in the early stages of cancer development.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8608985     DOI: 10.1002/(SICI)1097-0215(19960422)69:2<152::AID-IJC15>3.0.CO;2-B

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

Review 1.  Human papillomavirus types 16 and 18 in epithelial dysplasia of oral cavity and oropharynx: a meta-analysis, 1985-2010.

Authors:  Vijayvel Jayaprakash; Mary Reid; Elizabeth Hatton; Mihai Merzianu; Nestor Rigual; James Marshall; Steve Gill; Jennifer Frustino; Gregory Wilding; Thom Loree; Saurin Popat; Maureen Sullivan
Journal:  Oral Oncol       Date:  2011-08-03       Impact factor: 5.337

Review 2.  HPV and oral lesions: preventive possibilities, vaccines and early diagnosis of malignant lesions.

Authors:  D Testi; M Nardone; P Melone; P Cardelli; L Ottria; C Arcuri
Journal:  Oral Implantol (Rome)       Date:  2016-07-25

Review 3.  Human papillomavirus and head and neck squamous cell carcinoma: recent evidence and clinical implications.

Authors:  P T Hennessey; W H Westra; J A Califano
Journal:  J Dent Res       Date:  2009-04       Impact factor: 6.116

4.  p53 alterations in recurrent squamous cell cancer of the head and neck refractory to radiotherapy.

Authors:  I Ganly; D S Soutar; R Brown; S B Kaye
Journal:  Br J Cancer       Date:  2000-01       Impact factor: 7.640

Review 5.  Evidences suggesting involvement of viruses in oral squamous cell carcinoma.

Authors:  Kanupriya Gupta; Rashmi Metgud
Journal:  Patholog Res Int       Date:  2013-12-19

6.  p53 mutations and human papillomavirus DNA in oral squamous cell carcinoma: correlation with apoptosis.

Authors:  J Y Koh; N P Cho; G Kong; J D Lee; K Yoon
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

Review 7.  Prevalence of human papillomavirus (HPV) in oral cavity and oropharynx.

Authors:  Therezita Peixoto Patury Galvão Castro; Ivo Bussoloti Filho
Journal:  Braz J Otorhinolaryngol       Date:  2006 Mar-Apr
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.